Effect of procalcitonin-guided treatment in patients with infections: A systematic review and meta-analysis

Infection

Volumn 37, Issue 6, 2009, Pages 497-507

  Tang, H ^a   Huang, T ^a   Jing, J ^a   Shen, H ^a   Cui, W ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ALGORITHM; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; COCHRANE LIBRARY; EMBASE; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; MEDLINE; META ANALYSIS; MORTALITY; PRESCRIPTION; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CALCITONIN; DRUG MONITORING; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77249139646     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-9034-2     Document Type: Review

References (42)

1. H.L. Evans S.N. Lefrak J. Lyman R.L. Smith T.W. Chong S.T. McElearney A.R. Schulman M.G. Hughes D.P. Raymond T.L. Pruett R.G. Sawyer 2007 Cost of gram-negative resistance Crit Care Med 35 89 95 10.1097/01.CCM.0000251496.61520. 75 17110877 (Pubitemid 46035682)
2. R. Gonzales J.F. Steiner A. Lum P.H. Barrett Jr 1999 Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults JAMA 281 1512 1519 10.1001/jama.281.16.1512 1:STN:280:DyaK1M3ktFylsg%3D%3D 10227321 (Pubitemid 29200935)
3. D. Guillemot P. Courvalin 2001 Better control of antibiotic resistance Clin Infect Dis 33 542 547 10.1086/322583 1:STN:280:DC%2BD3Mvht1Smsg%3D%3D 11462192 (Pubitemid 32709588)
4. S. Harbarth V. Nobre D. Pittet 2007 Does antibiotic selection impact patient outcome? Clin Infect Dis 44 87 93 10.1086/510075 17143822 (Pubitemid 44968991)
5. R. El Moussaoui B.M. Roede P. Speelman P. Bresser J.M. Prins P.M. Bossuyt 2008 Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies Thorax 63 415 422 10.1136/thx.2007.090613 18234905 (Pubitemid 351692349)
6. T.M. File Jr L.A. Mandell 2003 What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 36 396 398 10.1086/367545 12567295 (Pubitemid 36241303)
7. G.S. Tillotson G.V. Doern J.M. Blondeau 2006 Optimal antimicrobial therapy: the balance of potency and exposure Expert Opin Investig Drugs 15 335 337 10.1517/13543784.15.4.335 1:CAS:528:DC%2BD28XivVOmsLY%3D 16548783
8. D.N. Fish 2002 Optimal antimicrobial therapy for sepsis Am J Health Syst Pharm 59 Suppl1 S13 S19 1:CAS:528:DC%2BD38Xhs1Wisr4%3D 11885408
9. M. Christ-Crain B. Muller 2007 Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur Respir J 30 556 573 10.1183/09031936.00166106 1:CAS:528:DC%2BD2sXhtFGgsb3N 17766633 (Pubitemid 351182082)
10. W. Oczenski R.D. Fitzgerald S. Schwarz 1998 Procalcitonin: a new parameter for the diagnosis of bacterial infection in the perioperative period Eur J Anaesthesiol 15 202 209 1:STN:280:DyaK1c3kvFejug%3D%3D 9587727
11. B. Muller K.L. Becker 2001 Procalcitonin: how a hormone became a marker and mediator of sepsis Swiss Med Wkly 131 595 602 1:CAS:528:DC%2BD38XhtlGktrw%3D 11820070
12. B. Muller K.L. Becker M. Kranzlin H. Schachinger P.R. Huber E.S. Nylen R.H. Snider J.C. White H. Schmidt-Gayk W. Zimmerli R. Ritz 2000 Disordered calcium homeostasis of sepsis: association with calcitonin precursors Eur J Clin Invest 30 823 831 10.1046/j.1365-2362.2000.00714.x 1:CAS:528: DC%2BD3cXntVymu7g%3D 10998084 (Pubitemid 30690628)
13. C.H. Yang D.C.T. Lu 2006 Clinical applications of procalcitonin (ProCT) J Intern Med Taiwan 17 1 10 1:CAS:528:DC%2BD2sXmvFGnsb8%3D
14. C. Chirouze H. Schuhmacher C. Rabaud H. Gil N. Khayat J.M. Estavoyer T. May B. Hoen 2002 Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever Clin Infect Dis 35 156 161 10.1086/341023 1:CAS:528:DC%2BD38XmsVagtbg%3D 12087521 (Pubitemid 34753900)
15. M. Ebell 2008 Procalcitonin-guided treatment of respiratory tract infections Am Fam Physician 78 756 757 18819243
16. F.J. Martinez J.L. Curtis 2007 Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there Chest 131 1 2 10.1378/chest.06-2567 17218546 (Pubitemid 46122964)
17. Y. Shehabi I. Seppelt 2008 Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 12 211 10.1186/cc6860 18466649
18. Higgins JPT, Altman DG: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds): Ochrane handbook for systematic reviews of interventions 5.0.0. Wiley: London 2008.
19. J. Wen Y. Ren L. Wang Y. Li Y. Liu M. Zhou P. Liu L. Ye W. Tian 2008 The reporting quality of meta-analyses improves: a random sampling study J Clin Epidemiol 61 770 775 10.1016/j.jclinepi.2007.10.008 18411041
20. D. Moher D.J. Cook S. Eastwood I. Olkin D. Rennie D.F. Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1896 1900 10.1016/S0140-6736(99)04149-5 1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D 10584742
21. R. DerSimonian 1990 Combining evidence from clinical trials Anesth Analg 70 475 476 10.1213/00000539-199005000-00001 1:STN:280:DyaK3c3jtlCqsQ%3D%3D 2139548
22. J.P. Higgins S.G. Thompson 2002 Quantifying heterogeneity in a metaanalysis Stat Med 21 1539 1558 10.1002/sim.1186 12111919 (Pubitemid 34746062)
23. M. Egger G. Davey Smith M. Schneider C. Minder 1997 Bias in metaanalysis detected by a simple, graphical test Br Med J 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D
24. K.L. Soeken A. Sripusanapan 2003 Assessing publication bias in metaanalysis Nurs Res 52 57 60 10.1097/00006199-200301000-00009 12552177
25. M. Christ-Crain D. Jaccard-Stolz R. Bingisser M.M. Gencay P.R. Huber M. Tamm B. Muller 2004 Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 600 607 10.1016/S0140-6736(04) 15591-8 1:CAS:528:DC%2BD2cXhsVOnsLk%3D 14987884 (Pubitemid 38264177)
26. M. Christ-Crain D. Stolz R. Bingisser C. Muller D. Miedinger P.R. Huber W. Zimmerli S. Harbarth M. Tamm B. Muller 2006 Procalcitonin guidance of antibiotic therapy in communityacquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 84 93 10.1164/rccm.200512-1922OC 1:CAS:528: DC%2BD28XntF2ltbo%3D 16603606 (Pubitemid 43955248)
27. D. Stolz M. Christ-Grain R. Bingisser J. Leuppi D. Miedinger C. Muller P. Huber B. Muller M. Tamm 2007 Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 9 19 10.1378/chest.06-1500 1:CAS:528:DC%2BD2sXhs1alu7k%3D 17218551 (Pubitemid 46122969)
28. P. Svoboda I. Kantorova P. Scheer J. Radvanova M. Radvan 2007 Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepato-gastroenterology 54 359 363 1:CAS:528:DC%2BD2sXmtVyksL8%3D 17523274
29. M. Briel P. Schuetz B. Mueller J. Young U. Schild C. Nusbaumer P. Periat H.C. Bucher M. Christ-Crain 2008 Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care Arch Intern Med 168 2000 2007 10.1001/archinte.168.18.2000 18852401
30. M. Hochreiter T. Kohler A.-M. Schweiger F.S. Keck B. Bein T. Von Spiegel S. Schroder 2008 Antibiotic treatment of surgical intensive care patients. Procalcitonin to guide duration of therapy Anaesthesist 57 571 577 10.1007/s00101-008-1379-x 1:CAS:528:DC%2BD1cXntFGksLs%3D 18463831
31. V. Nobre S. Harbarth J.D. Graf P. Rohner J. Pugin 2008 Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial Am J Respir Crit Care Med 177 498 505 10.1164/rccm.200708- 1238OC 1:CAS:528:DC%2BD1cXjvFyqsrk%3D 18096708
32. K. Reinhart M. Meisner F.M. Brunkhorst 2006 Markers for sepsis diagnosis: what is useful? Crit Care Clin 22 503 519 10.1016/j.ccc.2006.03.003 1:CAS:528:DC%2BD2sXhtl2ns7jL 16893736 (Pubitemid 44163091)
33. S. Harbarth 2007 The effect of antimicrobial use on emergence and selection of resistance Anasthesiol Intensivmed Notfallmed Schmerzther 42 130 135 10.1055/s-2007-971165 17309021 (Pubitemid 46595123)
34. C. Carbon R.P. Bax 1998 Regulating the use of antibiotics in the community Br Med J 317 663 665 1:STN:280:DyaK1czpslartA%3D%3D
35. D. Guillemot P. Maison C. Carbon B. Balkau F. Vauzelle-Kervroedan C. Sermet G. Bouvenot E. Eschwege 1998 Trends in antimicrobial drug use in the community-France, 1981-1992 J Infect Dis 177 492 497 10.1086/517384 1:STN:280:DyaK1c7is1ShsA%3D%3D 9466546
36. B.M. Tang G.D. Eslick J.C. Craig A.S. McLean 2007 Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis Lancet Infect Dis 7 210 217 10.1016/S1473-3099(07)70052-X 1:CAS:528:DC%2BD2sXjs12msL8%3D 17317602 (Pubitemid 46274517)
37. A.E. Jones J.F. Fiechtl M.D. Brown J.J. Ballew J.A. Kline 2007 Procalcitonin test in the diagnosis of bacteremia: a meta-analysis Ann Emerg Med 50 34 41 10.1016/j.annemergmed.2006.10.020 17161501 (Pubitemid 46907302)
38. E. Nylen B. Muller K.L. Becker R. Snider 2003 The future diagnostic role of procalcitonin levels: the need for improved sensitivity Clin Infect Dis 36 823 824 10.1086/368088 12627371 (Pubitemid 36337992)
39. K.L. Becker R. Snider E.S. Nylen 2008 Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations Crit Care Med 36 941 952 10.1097/CCM.0B013E318165BABB 1:CAS:528:DC%2BD1cXjtlyhsbc%3D 18431284
40. H.G. Schneider Q.T. Lam 2007 Procalcitonin for the clinical laboratory: a review Pathology 39 383 390 10.1080/00313020701444564 1:CAS:528: DC%2BD2sXosFaku7c%3D 17676478 (Pubitemid 47221465)
41. M. Christ-Crain P. Schuetz A.R. Huber B. Muller 2008 Procalcitonin - importance for the diagnosis of bacterial infections Ther Umsch 65 559 568 10.1024/0040-5930.65.9.559 18791971
42. M. Meisner 2002 Pathobiochemistry and clinical use of procalcitonin Clin Chim Acta 323 17 29 10.1016/S0009-8981(02)00101-8 1:CAS:528:DC%2BD38Xls1agtbw%3D 12135804 (Pubitemid 34804792)